Home
Foresite Capital Fund VI reported a 14.5% stake in Latigo Biotherapeutics LTGO · 9,181,328 sh
Trade details
- Type
- 5% stake report
- Report
- 13D
- Stake
- 14.5%
- Last report
- First report
- Shares held
- 9,181,328 sh
- Class
- Common Stock
- Holder
- Foresite Capital Fund VI
- Event date
- 26/08/10
- Filed
- 26/08/17
First 5%+ report · 14.5% stake
Latigo Biotherapeutics trades, last 26 weeks
What else happened in Latigo Biotherapeutics around then
Filed or reported within 30 days of the trade day · 07/11~09/09Foresite Capital Fund VI's other 5% stake reports
- Foresite Capital Fund VI
5% stakeAlumis
5% stakeAlumis
ALMS
14.5% stake
9,181,328 sh
14.5% stake
Filed 08/17
- Foresite Capital Fund VI
5% stakeVerastem
5% stakeVerastem
VSTM
3.6% stake
3,146,631 sh
3.6% stake
Filed 05/15
- Foresite Capital Fund VI
5% stakeAlumis
5% stakeAlumis
ALMS
12.7% stake
15,693,820 sh
12.7% stake
Filed 04/03
- Foresite Capital Fund VI
5% stakeCasi Pharmaceuticals
5% stakeCasi Pharmaceuticals
CASIF
0% stake
0 sh
0% stake
Filed 02/13
- Foresite Capital Fund VI
5% stakeAlumis
5% stakeAlumis
ALMS
14.1% stake
16,189,804 sh
14.1% stake
Filed 01/12
